Discovery of M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity.
Vlach J, Bender AT, Przetak M, Pereira A, Deshpande A, Johnson TL, Reissig S, Tzvetkov E, Musil D, Morse NT, Haselmayer P, Zimmerli SC, Okitsu SL, Walsky RL, Sherer B.
Vlach J, et al. Among authors: tzvetkov e.
J Pharmacol Exp Ther. 2021 Mar;376(3):397-409. doi: 10.1124/jpet.120.000275. Epub 2020 Dec 16.
J Pharmacol Exp Ther. 2021.
PMID: 33328334